Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/29/09
Dejgaard A et al. – In these randomised controlled diabetes trials, patients treated with insulin detemir had a lower or similar occurrence of a cancer diagnosis compared with patients treated with NPH insulin or insulin glargine, respectively.
Related Articles
Insulin detemir causes increased symptom awareness during hypoglycaemia compared to human insulin
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 69%
Rationale, Design, and Baseline Data of the Insulin Glargine (Lantus) Versus Insulin Detemir (Levemir) Treat-To-Target (L2T3) Study: A Multinational, Randomized Noninferiority Trial of Basal Insulin Initiation in Type 2 Diabetes
Diabetes Technology & Therapeutics, 11/17/09
Relevance Score: 68%
Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study
Current Medical Research and Opinion, 10/02/09
Relevance Score: 68%
Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins
Diabetic Medicine, 10/07/09
Relevance Score: 67%
Superior efficacy-dose ratio for Lantus over detemir
Sanofi-aventis, 10/01/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Individuation of different metabolic phenotypes in normal glucose tolerance test
Acta Diabetologia, 11/25/09
Are Hemoglobin Levels Elevated in Type 1 Diabetes
Diabetes Care, 11/25/09
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


